ClinicalTrials.gov identifier: NCT03036124
Iron-chelating drugs enhance cone photoreceptor survival in a mouse model of retinitis pigmentosa
The table below shows this is is a comparable effect to statins in secondary prevention
Cani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A, Rottier O, et al
Acute systemic administration of combined drug treatments with amylin, GLP-1, sCT and liraglutide We first aimed to investigate the behavioral mechanism by which combined activation of amylin receptors and GLP-1R suppress food intake in lean rodents using various pharmacological combinations of native amylin with native GLP-1(736), as well as combined administration of the amylin receptor/calcitonin receptor agonist, sCT, together with the GLP-1R agonist, liraglutide
Patients choose Dr